Idexx Laboratories (IDXX) Receivables - Net (2009 - 2026)

Idexx Laboratories (IDXX) has reported Receivables - Net for 18 consecutive years, with $603.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Receivables - Net rose 14.42% year-over-year to $603.5 million; the TTM figure through Mar 2026 stood at $603.5 million (up 14.42% YoY), while the FY2025 annual figure was $552.4 million, up 16.64% from the prior year.
• Receivables - Net came in at $603.5 million for Q1 2026 at Idexx Laboratories, up from $552.4 million in the prior quarter.
• The five-year high for Receivables - Net was $603.5 million in Q1 2026, with the low at $388.1 million in Q3 2022.
• Average Receivables - Net over 5 years is $485.8 million, with a median of $473.6 million recorded in 2024.
• Across the five-year window, Receivables - Net grew 3.0% in 2022 and climbed 16.65% in 2023, its largest moves.
• Year by year, Receivables - Net stood at $400.6 million in 2022, then climbed by 14.18% to $457.4 million in 2023, then gained by 3.53% to $473.6 million in 2024, then increased by 16.64% to $552.4 million in 2025, then gained by 9.26% to $603.5 million in 2026.
• According to Business Quant data, Receivables - Net over the past three periods registered $603.5 million, $552.4 million, and $566.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.